
Barry Marshall
1951 · Australian physician and microbiologist, Nobel laureate for the discovery of Helicobacter pylori
Also on: their science on Newtonpedia
Barry James Marshall was born in Kalgoorlie, Western Australia, on 30 September 1951. He was the eldest of four siblings. His father held a series of jobs during his childhood, and his mother was a nurse, so the world of health care was familiar to the family from the inside. Marshall lived in Kalgoorlie and Carnarvon until the age of eight, when the family moved to Perth, the state capital, which would be his home for much of his life.
He attended Marist College in Churchlands for his secondary education and then studied at the University of Western Australia School of Medicine, where he received the degree of Bachelor of Medicine and Bachelor of Surgery (MBBS) in 1974. This is the qualification that allows a doctor to practise medicine in much of the English-speaking world. He had married his wife Adrienne in 1972, while still training, and they had four children: a son and three daughters. Based on what he has said publicly and on the available records, his family life provided a stable setting for the most intense years of his research.
In 1979 he was appointed registrar in medicine at the Royal Perth Hospital, the city's major public hospital. During his postgraduate training in internal medicine there, in 1981, he met Dr Robin Warren, a pathologist who was interested in gastritis. A pathologist is a doctor who studies tissues and samples under the microscope to determine which disease a patient has. Gastritis is inflammation of the stomach lining, the layer that covers the inside of the organ. Warren had been observing spiral-shaped bacteria in stomach biopsies, small samples of tissue taken for examination, and they were often found alongside inflammation. Marshall, who was early in his clinical career, joined him in studying this link.
To understand why their proposal was so significant, it helps to recall the medical climate of the time. For decades the dominant explanation of peptic ulcers, open sores in the lining of the stomach or the first part of the small intestine, held that they were caused by stress, spicy food and, above all, too much stomach acid. The stomach was assumed to be too hostile an environment for any bacterium to survive in. Treatment focused on reducing acidity, and few researchers considered that an infection might be behind the problem. In 1982, Marshall and Warren managed to grow H. pylori in culture for the first time, and they developed the hypothesis that a bacterial infection was the cause of many peptic ulcers and of a form of stomach cancer.
The road to proving it was slow and full of obstacles. That same year they obtained funding for one year of research. The first 30 of 100 samples did not support their hypothesis. It later emerged that laboratory technicians were discarding cultures after two days, a routine practice for throat swabs, because other organisms from the mouth made the cultures unusable after that point. Because of other hospital duties, the 31st sample was not thrown out on time and stayed in the laboratory from Thursday until the following Monday. In that sample, H. pylori appeared. They later found that this bacterium grows more slowly than the bacteria normally cultured over two days, and that stomach samples were not contaminated by other microorganisms. In 1983 they presented their findings to the Gastroenterological Society of Australia, but the reviewers rejected the paper and placed it in the bottom 10 per cent of those received that year.
In 1984 their attempts to infect piglets failed. Marshall then took a decision that has become central to his reputation: he underwent a baseline endoscopy, an examination in which a flexible tube with a camera is passed through the mouth to view the stomach, and afterwards he drank a broth containing H. pylori grown in the laboratory. He expected that, perhaps years later, he might develop an ulcer. Instead, after three days he felt mild nausea and noticed bad breath, which he attributed to achlorhydria, the absence of hydrochloric acid in the stomach. Without enough acid to kill the bacteria, their waste products showed up as halitosis, and his wife was the first to notice it. Between days five and eight he had vomiting without acid. On the eighth day a repeat endoscopy showed marked inflammation, that is, gastritis, and a biopsy yielded a culture of H. pylori, showing that the bacterium had colonised his stomach. On the fourteenth day a third endoscopy was carried out and Marshall began taking antibiotics. He also did not develop antibodies against the bacterium, which suggested that the body's innate immune system, the first line of defence, can sometimes clear an acute infection.
The experiment broadly followed Koch's postulates, a set of criteria formulated in the nineteenth century by Robert Koch to link a microorganism rigorously to a disease. The case met these criteria for gastritis but not for peptic ulcer, which required further evidence. The work was published in 1985 in the Medical Journal of Australia, and it is among the most cited articles in that journal. It should be noted that the collaboration between Marshall and Warren had first appeared in The Lancet in 1984, and that in Australia their work was regarded as one of the major medical developments of recent times.
His career then moved between several centres. He worked at Fremantle Hospital and then at the Royal Perth Hospital from 1985 to 1986, before going to the University of Virginia in the United States, where he remained on the faculty while returning frequently to Australia. From 1998 to 2003 he held a Burnet Fellowship at the University of Western Australia. In 1994 he founded the Helicobacter Foundation, and his research extended into epidemiology, the study of how diseases are distributed across populations. Later studies established that H. pylori is responsible for more than 90 per cent of duodenal ulcers and up to 80 per cent of gastric ulcers.
The initial reception was largely one of scepticism. It has been claimed that the H. pylori theory was ridiculed by established scientists and doctors, who did not believe that a bacterium could survive in such an acidic environment. In 1998, Marshall was quoted as saying: “Everyone was against me, but I knew I was right.” Some historians argue, however, that the scientific community showed a reasonable degree of caution, which was understandable given that the idea challenged decades of accepted doctrine, and that acceptance came once sufficient evidence existed. Both readings can be held together: the rejection was real, but so was the demand for proof. The rivalries and difficulties in securing funding and publication belong to this period, although the details of particular disputes are not always well documented.
Recognition came in the form of many awards. In 1994 he received the Warren Alpert Foundation Prize, shared with Warren, and in 1995 the Albert Lasker Award, which many regard as a common precursor to the Nobel Prize. In 1996 he received the Gairdner Foundation International Award, and in 1997 the Paul Ehrlich and Ludwig Darmstaedter Prize. In 1998 came the Buchanan Medal of the Royal Society and other honours, and in 1999 he was elected a Fellow of the Royal Society. Finally, on 3 October 2005, the Karolinska Institute's Nobel Assembly awarded the Nobel Prize in Physiology or Medicine to Marshall and Warren for their discovery of the bacterium and its role in gastritis and peptic ulcer disease.
After the Nobel Prize, Marshall remained very active. In 2007 he was appointed Co-Director of the Marshall Centre for Infectious Diseases Research and Training, which was founded in his honour, and that same year he accepted a part-time appointment at Pennsylvania State University. In 2017 he established the Noisy Guts Project, a team devoted to investigating new diagnostics and treatments for irritable bowel syndrome, a chronic digestive disorder, and this led to a spin-out company that develops functional food products. In August 2020 he joined, together with Simon J. Thorpe, the scientific advisory board of Brainchip, a computer chip company.
Marshall's legacy is twofold. On one hand, his work changed how stomach diseases are understood, so that many of them came to be seen as largely infectious rather than purely functional. This opened the way to treatments based on antibiotics and bismuth salts, whose role in healing duodenal ulcers was studied. On the other hand, he left a methodological example that is often cited: his self-experimentation, although others had tried similar approaches before, raised ethical and scientific questions that remain part of the discussion. He was appointed a Companion of the Order of Australia in 2007, in 2015 the science library of his university was renamed the Barry J Marshall Library, and he serves as an ambassador for the life sciences in Western Australia. The link between H. pylori and stomach cancer remains an active area of research, and his story is a reminder that an idea rejected for years can end up transforming medical practice.
Contributions
- Helicobacter pylori: a bacterium that lives in the stomach lining and is linked to many ulcers and some stomach cancers.
- Self-administration experiment: in 1984 he drank a culture of the bacterium to test the hypothesis, and the case was published in 1985.
- Challenge to medical doctrine: his work questioned the idea that ulcers were caused mainly by stress or acid.
- Nobel Prize in Physiology or Medicine (2005): shared with Robin Warren for the discovery of H. pylori.
Curiosities and anecdotes
A self-experiment
Marshall drank the H. pylori culture after a baseline endoscopy, expecting an ulcer perhaps years later. Symptoms appeared within days.
A forgotten culture
The sample that allowed the bacterium to be identified was kept longer than usual because technicians had no time to discard it on schedule.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.